Evidence map›Paper›PMID 30042924›Full record

ArticleJournal of bone oncology2018

Bone metastases in biliary cancers: A multicenter retrospective survey.

D Santini, G Brandi, G Aprile, M Russano, S Cereda, F Leone, S Lonardi, L Fornaro, M Scartozzi, N Silvestris and 17 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bone oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 10 institutions in 1 country.

D SantiniDepartment of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
G BrandiDepartment of Experimental, Diagnostic and Speciality Medicine, Sant'Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
G AprileDepartment of Oncology, San Bortolo Hospital, ULSS8 Berica-East District, Vicenza, Italy.
M RussanoDepartment of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
S CeredaDepartment of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.
F LeoneDepartment of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
S LonardiMedical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.
L FornaroUnit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Italy.
M ScartozziMedical Oncology, Hospital & University of Cagliari, Italy.
N SilvestrisMedical Oncology Unit, Cancer Institute ``Giovanni Paolo II'', 70124 Bari, Italy.
S BarniMedical Oncology Unit, ASST Bergamo Ovest, Piazzale Ospedale 1, 24047 Treviglio, Bergamo, Italy.
F PantanoDepartment of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
B VincenziDepartment of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
A PalloniDepartment of Experimental, Diagnostic and Speciality Medicine, Sant'Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
G FregaDepartment of Experimental, Diagnostic and Speciality Medicine, Sant'Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
M CasagrandeDepartment of Oncology, University and General Hospital, Udine, Italy.
L FerrariDepartment of Oncology, University and General Hospital, Udine, Italy.
V DadduzioMedical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.
R IntiniMedical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.
R FilippiDepartment of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
E VasileUnit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Italy.
C VivaldiUnit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Italy.
L FaloppiMedical Oncology, Hospital of Macerata, Macerata, Italy & Medical Oncology, University of Cagliari, Italy.
O BrunettiMedical Oncology Unit, Cancer Institute ``Giovanni Paolo II'', 70124 Bari, Italy.
M ReniDepartment of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.
M AgliettaDepartment of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
G ToniniDepartment of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
University of Udine · ITIstituto Oncologico Veneto · ITUniversità Campus Bio-Medico · ITCandiolo Cancer Institute · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITAzienda Ospedaliera Universitaria Pisana · ITAzienda Socio Sanitaria Territoriale di Bergamo OvestIstituto Tumori Bari · ITSan Raffaele University of Rome · ITUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Natural history of biliary cancers metastatic to bone•The role of skeletal events in patients with biliary cancer•Biliary cancer and bone metastases: role of bisphosphonates.

Identifiers

PMID30042924
PMCPMC6054714
OpenAlexW2796668941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.